CNBC·3 min read·medium
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
A
Annika Kim Constantino
✦AI Summary
Vivani Medical is developing a long-term semaglutide implant designed to help patients maintain weight loss and improve adherence to GLP-1 treatments. The company has partnered with Novo Nordisk to evaluate the device, which aims to replace frequent injections with a twice-yearly or annual implant.
Losing weight with GLP-1 drugs is only half the battle. Keeping it off long term has proved even harder.
businesshealthtechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in